Gastric cancer is a major source of global cancer mortality with limited treatment options and
poor patient survival. As our molecular understanding of gastric cancer improves, we are …

Despite the global decline in the incidence and mortality of gastric cancer, it remains one of
the most common malignant tumors of the digestive system. Although surgical resection is …

Gastric cancer is currently the second leading cause of worldwide cancer mortality. Ongoing
collaborative sequencing efforts have highlighted recurrent somatic genomic aberrations in …

Gastric cancer (GC) remains the third most common cause of cancer death worldwide, with
limited therapeutic strategies available. With the advent of next-generation sequencing and …

Gastric cancer imposes a considerable health burden around the globe despite its declining
incidence. The disease is often diagnosed in advanced stages and is associated with a poor …

Gastric cancer (GC) is the third leading cause of cancer mortality worldwide. Although
surgical resection is a potentially curative approach for localized cases of GC, most cases of …

Despite a decrease in incidence over past decades, gastric cancer remains a major global
health problem. In the more recent period, survival has shown only minor improvement …

Gastric cancer (GC) ranks fifth in global cancer diagnosis and fourth in cancer-related death.
Despite tremendous progress in diagnosis and therapeutic strategies and significant …

Gastric cancer is one of the most incident and deadliest malignancies in the world. Gastric
cancer is a heterogeneous disease and the end point of a long and multistep process, which …

Gastric cancer is a cause of significant morbidity and cancer-related mortality worldwide.
Despite recent advances in targeted therapy and understanding of the biology and …